Safety and effectiveness of fosravuconazole for the treatment of onychomycosis in haemodialysis patients: A single-centre retrospective study

J Eur Acad Dermatol Venereol. 2023 Dec;37(12):e1455-e1457. doi: 10.1111/jdv.19363. Epub 2023 Aug 1.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antifungal Agents / adverse effects
  • Dermatologic Agents*
  • Humans
  • Onychomycosis* / drug therapy
  • Renal Dialysis
  • Retrospective Studies
  • Treatment Outcome

Substances

  • Antifungal Agents
  • Dermatologic Agents